Observational study of effects of HIV Acquisition and Antiretroviral Treatment on Biomarkers of Systemic Immune Activation

OBJECTIVE: Assess whether biomarkers of systemic inflammation are associated with HIV acquisition or with the timing of ART initiation (“immediate”, at diagnosis, versus “deferred”, at 24 weeks postdiagnosis) in men-who-have-sex-with-men (MSM) and transgender women.

DESIGN: A retrospective study comparing inflammatory biomarkers in participants’ specimens collected before and after ≥2 years of effective ART.

METHODS: Inflammatory biomarkers were measured in four longitudinally collected plasma specimens, including two plasma specimens collected from each participant before and two after HIV acquisition and confirmed ART-suppression.

Biomarkers were quantified by enzyme-linked immuno-assay or Meso Scale Discovery.

Statistical measures compared intra-participant and between-group changes in biomarkers.

RESULTS: Across 50 participants, the levels of C-reactive protein (CRP), monocyte chemo-attractant protein-1, tumor necrosis factor-α and interferon gamma-induced protein-10 significantly increased while leptin and lipopolysaccharide binding protein (LBP) significantly decreased following HIV infection.

Randomization to deferred-ART initiation was associated with greater increases in CRP and no decreases in LBP.

Multiple biomarkers varied significantly within participants’ two pre-infection or two post-ART-suppression specimens.

CONCLUSIONS: Acquisition of HIV appeared to induce systemic inflammation, with elevation of biomarkers previously associated with infections and cardiovascular disease.

Initiation of ART during the early weeks of infection tempered the increase in pro-inflammatory biomarkers compared to those who delayed ART for ∼24 weeks after HIV diagnosis, perhaps because immediate-ART limited the size of the HIV reservoir or limited immune dysregulation.

Some but not all biomarkers appeared sufficiently stable to assess intraparticipant changes over time.

Given that pro-inflammatory biomarkers predict multiple co-morbidities, our findings suggest that immediate-ART initiation may improve health outcomes.